Phase II Trial of Risk-Enabled Therapy After Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer (RETAIN 1)
肌层浸润性膀胱癌新辅助化疗后风险赋能疗法的 II 期试验 (RETAIN 1)
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO-24-01214
Geynisman, Daniel M; Abbosh, Philip H; Ross, Eric; Zibelman, Matthew R; Ghatalia, Pooja; Anari, Fern; Mark, James R; Stamatakis, Lambros; Hoffman-Censits, Jean H; Viterbo, Rosalia; Greenberg, Richard E; Churilla, Thomas M; Horwitz, Eric M; Hallman, Mark A; Smaldone, Marc C; Uzzo, Robert; Chen, David Y T; Kutikov, Alexander; Plimack, Elizabeth R